Canaccord Genuity’s U.S. Investment Banking Team Completes ...
4
Canaccord Genuity’s U.S. Investment Banking Team Completes 207 Transactions in the Last Twelve Months Selected Transactions Announced Trailing Twelve Months as of 3/31/21
Transcript of Canaccord Genuity’s U.S. Investment Banking Team Completes ...
Canaccord Genuity’s U.S. Investment Banking Team Completes 207 Transactions in the Last Twelve Months
Selected Transactions Announced Trailing Twelve Months as of 3/31/21
Ranked #1 for Middle Market TMT Deal Activity1
Ranked #1 for Media & Information Services Deal Activity1
A Leading Investment Bank for U.S. Middle Market Healthcare Transactions 2
Leading Global Underwriter Supports M&A Activity – The Only Non Bulge-Bracket Bank in the Global Top 103
1Source: PitchBook for the time period 1/1/2018-12/31/2020. TMT stands for Technology, Media, and Telecommunications. Middle-Market TMT transaction totals represent US-based Corporate & Strategic Mergers
and Acquisitions, all Buyout types, and Growth/Expansion transactions less than $500 million in the Technology, Media & Telecommunications industries. Media & Information Services transaction totals represent
Corporate & Strategic M&A, all Private Equity, IPO/Liquidity, and Venture Capital transactions in the Media & Information Services industry.
2Source: Dealogic data since 2010 for Middle-Market Healthcare transaction activity
3Source: Dealogic as of 3/31/21. Includes all IPO, Follow-Ons, & Convertsss
Rank Total Value No. Rank No. Rank No.
($M)
Goldman Sachs 1 908,832.4 1,325 1 1,297 75 28
Morgan Stanley 2 859,713.5 1,293 3 1,247 51 46
J.P. Morgan 3 806,454.4 1,290 2 1,255 65 35
Bank of America 4 748,565.0 1,063 4 1,023 56 40
Citi 5 707,220.7 1,035 5 997 59 38
Canaccord Genuity 6 103,164.5 972 7 730 2 242
Credit Suisse 7 507,386.5 831 6 793 59 38
UBS 8 377,745.0 604 8 574 72 30
Barclays 9 411,759.2 596 10 544 48 53
Stifel 10 179,337.8 594 12 378 3 216
Co-ManagerLead ManagerTotal RolesBank
Since Petsky Prunier joined the Canaccord Genuity Group in early 2019, the two firms have built a dominant, full-service middle market investment bank serving growth companies. With teams now fully integrated, the promise of the merger was realized in 2020, with Canaccord Genuity having a record year. Our firm’s significant volume of activity has continued into 2021. During the twelve months ended March 31, 2021, Canaccord Genuity’s US team:
• Completed 207 total transactions for 170 different corporate clients
• Acted as underwriter on 122 capital markets transactions, raising in excess of $46 billion in cumulative proceeds for more than 90 different issuers
o Book-ran 38 equity offerings and managed 29 announced “At-the-Market” programs, an increase of 65% and 300%, respectively, from the twelve months ended March 31, 2020
• Closed 56 advisory engagements, which ranged from strategic sales, private equity recaps, and divestitures to growth, mezzanine, and alternative financings
o More than 60% of our M&A activity involved Financial Sponsors on at least one side of the deal
• Was involved in seven SPAC-related transactions and mergers The US investment banking team, one of the most active investment banks in the middle market, continues to leverage deep industry expertise across a broad banking universe in practices including:
• TMMIS (Technology, Media, Marketing, and Information Services)
• Healthcare (Biotechnology, Biopharmaceuticals, IT, Services, Medical Technologies, Diagnostics, and Cannabis)
• Industrial & Sustainability (Building Technologies, Mobility, Renewables and Distributed Generation, Services, Smart Grid/Smart City, Energy Storage, Agriculture and Food)
Our firm’s track record of success is recognized by the financial sponsor community – approximately half of the firm’s engagements involve representing investor-backed companies; at the same time, our in-depth industry coverage also continues to position Canaccord Genuity’s US investment banking team as the go-to advisor for founder and management-owned businesses. Through its principal subsidiaries, Canaccord Genuity Group Inc. is a leading independent, full-service financial services firm, with operations in two principal segments of the securities industry: wealth management and capital markets. Since its establishment in 1950, the Company has been driven by an unwavering commitment to building lasting client relationships. We achieve this by generating value for our individual, institutional and corporate clients through comprehensive investment solutions, brokerage services and investment banking services. The Company has Wealth Management offices located in Canada, the UK, Guernsey, Jersey, the Isle of Man and Australia. The international capital markets division operates in North America, the UK & Europe, Asia, Australia and the Middle East. Canaccord Genuity Group Inc. is publicly traded under the symbol CF on the TSX. Our US investment banking team, which now has approximately 90 professionals in offices across the country, is part of a global group of more than 200 bankers that can be leveraged to bring resources to our clients. We welcome the opportunity to discuss your business and your strategic objectives. This document is provided for informational purposes only and does not constitute an offer or solicitation to buy or sell any securities discussed herein in any jurisdiction where such offer or solicitation would be prohibited. As a result, the securities discussed in this document may not be eligible for sale in some jurisdictions. This document is not, and under no circumstances should be construed as, a solicitation to act as a securities broker or dealer in any jurisdiction by any person or company that is not legally permitted to carry on the business of a securities broker or dealer in that jurisdiction. Investors should obtain advice based on their own individual circumstances before making an investment decision. This publication is intended for institutional client use only, not for further distribution.
To the fullest extent permitted by law, neither Canaccord Genuity, nor its affiliates nor any other person accepts any liabil ity whatsoever for any direct or consequential loss arising from any use of the information contained in this document.
This publication is a brief summary and does not purport to contain all available information on the subjects covered. Further information is available on request.
For US distribution only.
Copyright ©Canaccord Genuity LLC, 2021. Member FINRA/SIPC.
All rights reserved. All material presented in this document, unless specifically indicated otherwise, is under copyright to Canaccord Genuity, a division of Canaccord Genuity Group Inc., Canaccord Genuity Limited, and Canaccord Genuity LLC None of the material, nor its content, nor any copy of it, may be altered in any way, or transmitted to or distributed to any other party, without the prior express written permission of the entities listed above.
Dan Coyne
Co-Head US Banking
Boston
Scott Card
Managing Director
Boston
Jason Partenza
Managing Director
New York
Mark Young
Managing Director
Boston
David Istock
Managing Director
San Francisco
Matthew Kratter
Managing Director
New York
J.P. Michaud
Managing Director
Charlotte
Tom Pollard
Managing Director
New York
Trevor Martin
Managing Director
Boston
Michael Petsky
Managing Director
New York
Isaiah Knouff
Managing Director
Nashville
Jeff Barlow
President
Boston
Dudley Baker
Managing Director
Nashville
Sanjay Chadda
Co-Head US & Tech Banking
New York
Lisa McClure Byrnes
Managing Director
Boston
Amy LaBan, CFA
Managing Director
Chicago
Seth Rosenfield
Managing Director
New York
Canaccord Genuity U.S. Senior Investment Banking Team
Andrew Pojani
Co-Head US
Tech Banking
Boston
Eugene Rozelman
Co-Head of US
Healthcare IB
New York
John Prunier
Managing Director
New York
Marc Marano
Managing Director
Boston
Matt Steere
Co-Head of US
Healthcare IB
San Francisco
John Stack
Managing Director
New York
Jen Pardi
Global Head of ECM
Boston
Morgan Ley
Managing Director
Boston
Anil Kuruganti
Director
New York
Christopher Heasman
Director
New York
Geoff Rhizor
Director
San Francisco
Lexia Schwartz
Director
New York
Edin Trto
Director
New York
Bernard Yuen
Director
New York
Matthew Kebel
Director
New York
Clayton Young
Director
New York
Tom O’Connor
Co-Head of US
Healthcare IB
New York
Ben Lunka
Managing Director
Charlotte
Chris DiPietro
Director
Boston
